The Impact of Prolonged Duration of Untreated Illness on Clinical Correlates in Chronic Schizophrenia: Exploring the Relationship With Suicide Risk

키워드

참고문헌 (76)

1. Carpenter WT Jr, "Schizophrenia", N Engl J Med, 330, pp.681~690 (1994)
2. Häfner H, "Epidemiology of schizophrenia", Can J Psychiatry, 42, pp.139~151 (1997)
3. Huang Y, "Prevalence of men tal disorders in China : a cross-sectional epidemiological study", Lancet Psychiatry, 6, pp.211~224 (2019)
4. Kahn RS, "Schizophrenia", Nat Rev Dis Primers, 1, pp.15067~ (2015)
5. Zhu MH, "Amisulpride aug mentation therapy improves cognitive performance and psychopathol ogy in clozapine-resistant treatment-refractory schizophrenia : a 12week randomized, double-blind, placebo-controlled trial", Mil Med Res, 9, pp.59~ (2022)
6. Rhee TG, "Does improvement in symptoms and quality of life in chronic schizophrenia reduce family caregiver burden?", Psychiatry Res, 271, pp.402~404 (2019)
7. Murru A, "Duration of untreated illness as a key to early intervention in schizophrenia : a review", Neurosci Lett, 669, pp.59~67 (2018)
8. Owens DC, "Duration of untreated illness and outcome in schizophrenia : test of predictions in relation to relapse risk", Br J Psychiatry, 196, pp.296~301 (2010)
9. Lieberman JA, "Early detection and preventive in tervention in schizophrenia : from fantasy to reality", Am J Psychiatry, 176, pp.794~810 (2019)
10. Jääskeläinen E, "A systematic review and meta-analysis of recovery in schizophre nia", Schizophr Bull, 39, pp.1296~1306 (2013)
11. Salomon C, "Antipsychotic discontinuation syndromes : a narrative review of the evidence and its integration into Australian mental health nursing textbooks", Int J Ment Health Nurs, 23, pp.6978~ (2014)
12. Huhn M, "Comparative efficacy and tolerability of 32 oral anti psychotics for the acute treatment of adults with multi-episode schizo phrenia : a systematic review and network meta-analysis", Lancet, 394, pp.939~951 (2019)
13. Nkire N, "Mixed-ef fects models reveal prediction of long-term outcome by duration of un treated psychosis(DUP)and illness(DUI)varies with quantile grada tion but is invariant with time across 7 years in the Cavan-Monaghan f irst episode psychosis study(CAMFEPS)", Schizophr Res, 248, pp.124130~ (2022)
14. Johns LC, "Prevalence and correlates of self-reported psychotic symptoms in the British population", Br J Psychiatry, 185, pp.298~305 (2004)
15. Shevlin M, "The distribution of positive psychosis-like symptoms in the population : a latent class analy sis of the national comorbidity survey", Schizophr Res, 89, pp.101~109 (2007)
16. Tandon R, "Definition and description of schizophrenia in the DSM-5", Schizophr Res, 150, pp.3~10 (2013)
17. Jonas KG, "Lead-time bias confounds association between duration of untreated psychosis and illness course in schizophrenia", Am J Psychiatry, 177, pp.327~334 (2020)
18. Nkire N, "Systematic comparison of duration of untreated illness versus dura tion of untreated psychosis in relation to psychopathology and dys function in the Cavan-Monaghan first episode psychosis study(CAM FEPS)", Eur Neuropsychopharmacol, 47, pp.20~30 (2021)
19. Olfson M, "Sui cide risk in medicare patients with schizophrenia across the life span", JAMA Psychiatry, 78, pp.876~885 (2021)
20. Grigoriou M, "Blunted affect and suicide in schizophre nia : a systematic review", Psychiatry Res, 293, pp.113355~ (2020)
21. Miller BJ, "Meta-analysis of insomnia, suicide, and psycho pathology in schizophrenia", Curr Opin Psychiatry, 36, pp.156~165 (2023)
22. Sarraf L, "The clinical and psychosocial correlates of self-stigma among people with schizophrenia spectrum disorders across cultures : a systematic review and meta-analysis", Schizophr Res, 248, pp.64~78 (2022)
23. Valery KM, "Schizophrenia stigma in mental health profes sionals and associated factors : a systematic review", Psychiatry Res, 290, pp.113068~ (2020)
24. Altamura AC, "Clinical vari ables related to suicide attempts in schizophrenic patients : a retrospec tive study", Schizophr Res, 60, pp.47~55 (2003)
25. Barrett EA, "Sui cidality before and in the early phases of first episode psychosis", Schizophr Res, 119, pp.11~17 (2010)
26. Mauri MC, "Suicide attempts in schizophrenic patients : clinical variables", Asian J Psychiatr, 6, pp.421~427 (2013)
27. Ran MS, "Duration of untreated psychosis(DUP)and outcome of people with schizophre nia in rural China : 14-year follow-up study", Psychiatry Res, 267, pp.340345~ (2018)
28. Preti A, "Risk of suicide and suicidal ideation in psychosis : results from an Ital ian multi-modal pilot program on early intervention in psychosis", Schizophr Res, 113, pp.145~150 (2009)
29. Luo G, "Duration of untreated illness and clinical correlates in first-episode and drug-naïve patients with ma jor depressive disorder", Psychiatry Res, 320, pp.115056~ (2023)
30. Dell’Osso B, "Reduced duration of untreated illness over time in patients with schizo phrenia spectrum, mood and anxiety disorders", Psychiatry Clin Neurosci, 70, pp.202~210 (2016)
31. Dell’osso B, "Duration of untreated psychosis and dura tion of untreated illness : new vistas", CNS Spectr, 15, pp.238~246 (2010)
32. Heitz U, "Gender differences in first self-perceived signs and symptoms in patients with an at-risk mental state and first-episode psychosis", Early Interv Psychiatry, 13, pp.582~588 (2019)
33. Pan XF, "Epidemiology and determinants of obesity in China", Lancet Diabetes Endocrinol, 9, pp.373~392 (2021)
34. de Beurs DP, "Lon gitudinal measurement invariance of the Beck Scale for Suicide Ide ation", Psychiatry Res, 225, pp.368~373 (2015)
35. Cha M, "Concordance between the Columbia-Suicide Severity Rating Scale and Beck Scale for Suicide Ideation in assessing suicide behaviour in young adults with schizophrenia spectrum disorders", Psychiatry Res, 319, pp.114965~ (2023)
36. Posner K, "The Columbia-Suicide Severity Rating Scale : initial validity and internal consistency findings from three multisite studies with adoles cents and adults", Am J Psychiatry, 168, pp.1266~1277 (2011)
37. Morin CM, "The Insomnia Severity Index : psychometric indicators to detect insomnia cases and evaluate treatment response", Sleep, 34, pp.601~608 (2011)
38. Chung KF, "Assessing insomnia in adolescents : comparison of Insomnia Severity Index, Athens Insomnia Scale and Sleep Quality Index", Sleep Med, 12, pp.463~470 (2011)
39. Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
40. Shrout PE, "Intraclass correlations : uses in assessing rater reli ability", Psychol Bull, 86, pp.420~428 (1979)
41. Randolph C, "The repeatable battery for the assessment of neuropsychological status(RBANS) : preliminary clinical validity", J Clin Exp Neuropsychol, 20, pp.310~319 (1998)
42. Zhang BH, "Gender differences in cognitive deficits in schizophrenia with and without dia betes", Compr Psychiatry, 63, pp.1~9 (2015)
43. Szklo M, "Epidemiology: beyond the basics" (2014), Jones & Bartlett Publishers
44. Benichou J, "Estimates of absolute cause-specific risk in co hort studies", Biometrics, 46, pp.813~826 (1990)
45. Stone WS, "Association be tween the duration of untreated psychosis and selective cognitive per formance in community-dwelling individuals with chronic untreated schizophrenia in rural China", JAMA Psychiatry, 77, pp.1116~1126 (2020)
46. Yu M, "Correlation between duration of untreated psychosis and long-term prognosis in chronic schizophrenia", Front Psychiatry, 14, pp.1112657~ (2023)
47. Deng F, "Com parison of social cognition using an adapted Chinese version of the reading the mind in the eyes test in drug-naive and regularly medicat ed individuals with chronic schizophrenia and healthy controls in rural China", Psychol Med, 52, pp.3655~3667 (2022)
48. Tang JY, "Pro spective relationship between duration of untreated psychosis and 13year clinical outcome : a first-episode psychosis study", Schizophr Res, 153, pp.1~8 (2014)
49. Zhao X, "Change of pov erty and outcome of persons with severe mental illness in rural China, 1994-2015", Int J Soc Psychiatry, 67, pp.315~323 (2021)
50. Ran MS, "Mor tality in people with schizophrenia in rural China : 10-year cohort study", Br J Psychiatry, 190, pp.237~242 (2007)
51. Wang YZ, "Affiliate stigma and caregiving burden among family caregivers of persons with schizophrenia in rural China", Int J Soc Psychiatry, 69, pp.1024~1032 (2023)
52. Ran MS, "Internal ized stigma in people with severe mental illness in rural China", Int J Soc Psychiatry, 64, pp.9~16 (2018)
53. Chien WT, "Perceived stigma of patients with se vere mental illness in Hong Kong : relationships with patients’ psycho social conditions and attitudes of family caregivers and health profes sionals", Adm Policy Ment Health, 41, pp.237~251 (2014)
54. Xu Z, "The state of mental health care in China", Asian J Psychiatr, 69, pp.102975~ (2022)
55. Liang D, "Integrated mental health services in China : challenges and planning for the future", Health Policy Plan, 33, pp.107~122 (2018)
56. Qian J, "Mental health care in China : providing services for under-treated patients", J Ment Health Policy Econ, 15, pp.179~186 (2012)
57. Zhang T, "Duration of untreat ed prodromal symptoms in a Chinese sample at a high risk for psycho sis : demographic, clinical, and outcome", Psychol Med, 48, pp.12741281~ (2018)
58. Brucato G, "Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psy chosis-risk cohort", Psychol Med, 47, pp.1923~1935 (2017)
59. Sabe M, "Thirty years of research on negative symptoms of schizophrenia : a scientomet ric analysis of hotspots, bursts, and research trends", Neurosci Biobehav Rev, 144, pp.104979~ (2023)
60. Strauss GP, "Avolition as the core negative symptom in schizophrenia : relevance to pharmacological treatment development", NPJ Schizophr, 7, pp.16~ (2021)
61. Gebreegziabhere Y, "Cogni tive impairment in people with schizophrenia : an umbrella review", Eur Arch Psychiatry Clin Neurosci, 272, pp.1139~1155 (2022)
62. Vita A, "Eu ropean Psychiatric Association guidance on treatment of cognitive im pairment in schizophrenia", Eur Psychiatry, 65, pp.e57~ (2022)
63. Javitt DC, "Cognitive impairment associated with schizophrenia : from pathophysiology to treatment", Annu Rev Pharmacol Toxicol, 63, pp.119~141 (2023)
64. Amminger GP, "Dura tion of untreated psychosis and cognitive deterioration in first-episode schizophrenia", Schizophr Res, 54, pp.223~230 (2002)
65. Zhou FC, "Characteristics and clinical correlates of prospective memory perfor mance in first-episode schizophrenia", Schizophr Res, 135, pp.34~39 (2012)
66. Cuesta MJ, "Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis", Schizophr Res, 141, pp.222~227 (2012)
67. Chang WC, "Im pacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia : a 3-year prospective follow up study", Psychol Med, 43, pp.1883~1893 (2013)
68. Bora E, "Duration of untreated psychosis and neurocognition in first-episode psychosis : a meta-anal ysis", Schizophr Res, 193, pp.3~10 (2018)
69. Galderisi S, "Correlates of cognitive impairment in first episode schizophrenia : the EUFEST study", Schizophr Res, 115, pp.104~114 (2009)
70. Teigset CM, "Do clinical characteristics predict the cognitive course in early-on set schizophrenia-spectrum disorders?", J Child Psychol Psychiatry, 59, pp.1012~1023 (2018)
71. Barnard-Kelly K, "Liraglutide and the management of overweight and obesity in peo ple with severe mental illness : qualitative sub-study", BMC Psychiatry, 22, pp.21~ (2022)
72. Chouinard VA, "Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders", Psychiatry Res, 237, pp.304~310 (2016)
73. Wyatt RJ, "Rationale for the study of early intervention", Schizophr Res, 51, pp.69~76 (2001)
74. de la Fuente-Sandoval C, "Higher levels of glutamate in the associa tive-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis", Neuropsychopharmacology, 36, pp.1781~1791 (2011)
75. Dickhoff J, "Relationship between social cognition, general cognition, and risk for suicide in individuals with a psychotic disorder", Schizophr Res, 231, pp.227~236 (2021)
76. Tarrier N, "Suicide schema in schizophrenia : the effect of emotional reactivity, nega tive symptoms and schema elaboration", Behav Res Ther, 45, pp.20902097~ (2007)

관련 논문AI추천